药物洗脱支架与裸金属支架治疗无保护左主干病变的效果比较(3)
[4] Silvestri M，Barragan P，Sainsous J，et al.Unprotected left main coronary artery stenting：immediate and medium-term outcomes of 140 elective procedures[J].J Am Coll Cardiol，2000，35(6)：1543-1550.
[5] Black A，Cortina R，Bossi I，et al.Unprotected left main coronary artery stenting：correlates of midterm survival and impact of patient selection[J].J Am Coll Cardiol，2001，37(3)：832-838.
[6] Park SJ，Hong MK，Lee CW，et al.Elective stenting of unprotected left main coronary artery stenosiseffect of debulking before stenting and intravascular ultrasound guidance[J].J Am Coll Cardiol，2001，38(4)：1054-1060.
[7] Chieffo A，Stankovic G，Bonizzoni E，et al.Early and mid-term results of drug-eluting stent implantation in unprotected left main[J].Circulation，2005，111(6)：791-795.
[8] Valgimigli M，van Mieghem CAG，Ong ATL，et al.Short-and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease insights from the rapamycin-eluting and taxus stent evaluated at Rotterdam Cardiology Hospital registries(RESEARCH and T-SEARCH)[J].Circulation，2005，111(11)：1383-1389.
[9] Park SJ，Kim YH，Lee BK，et al.Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosiscomparison with bare metal stent implantation[J].J Am Coll Cardiol，2005，45(3)：351-356.
[10] Kim YH，Park DW，Lee SW，et al.Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents[J].Circulation，2009，120(5)：400-407.
[11] Iakovou I，Schmidt T，Bonizzoni E，et al.Incidence，predictors，and outcome of thrombosis after successful implantation of drug-eluting stents[J].JAMA，2005，293(17)：2126-2130.
[12] Stone GW，Moses JW，Ellis SG，et al.Safety and efficacy of sirolimus and paclitaxel-eluting coronary stents[J].N Engl J Med，2007，356(10)：998-1008.
[13] Mauri L，Hsieh W，Massaro JM，et al.Stent thrombosis in randomized clinical trials of drug-eluting stents[J].N Engl J Med，2007，356(10)：1020-1029.
[14] Kuchulakanti PK，Chu WW，Torguson R，et al.Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus-and paclitaxel-eluting stents[J].Circulation，2006，113(8)：1108-1113.
[15] Kastrati A，Mehilli J，Pache J，et al.Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents[J].N Engl J Med，2007，356(10)：1030-1039.
[16] Tu JV，Bowen J，Chiu M，et al.Effectiveness and safety of drug-eluting stents in Ontario[J].N Engl J Med，2007， 357(14)：1393-1402.
[17] Marroquin OC，Selzer F，Mulukutla SR，et al.A comparison of bare-metal and drug-eluting stents for off-label indications[J].N Engl J Med，2008，358(4)：342-352.
[18] Han Y，Wang S，Jing Q，et al.Comparison of long-term efficacy of the paclitaxel-eluting stent versus the bare-metal stent for treatment of unprotected left main coronary artery disease[J].Am J Cardiol，2009，103(2)：194-198.
[19] Gao R，Xu B，Chen J，et al.Immediate and long-term outcomes of drug-eluting stent implantation for unprotected left main coronary artery disease：comparison with bare-metal stent implantation[J].Am Heart J，2008，155(3)：553-561.
[20] Lagerqvist B，James SK，Stenestrand U，et al.Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden[J].N Engl J Med，2007，356(10)：1009-1019.
(收稿日期：2014-10-31 本文编辑：李亚聪) (翟娜 张宇静 王明毅 关红 徐健)
[5] Black A，Cortina R，Bossi I，et al.Unprotected left main coronary artery stenting：correlates of midterm survival and impact of patient selection[J].J Am Coll Cardiol，2001，37(3)：832-838.
[6] Park SJ，Hong MK，Lee CW，et al.Elective stenting of unprotected left main coronary artery stenosiseffect of debulking before stenting and intravascular ultrasound guidance[J].J Am Coll Cardiol，2001，38(4)：1054-1060.
[7] Chieffo A，Stankovic G，Bonizzoni E，et al.Early and mid-term results of drug-eluting stent implantation in unprotected left main[J].Circulation，2005，111(6)：791-795.
[8] Valgimigli M，van Mieghem CAG，Ong ATL，et al.Short-and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease insights from the rapamycin-eluting and taxus stent evaluated at Rotterdam Cardiology Hospital registries(RESEARCH and T-SEARCH)[J].Circulation，2005，111(11)：1383-1389.
[9] Park SJ，Kim YH，Lee BK，et al.Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosiscomparison with bare metal stent implantation[J].J Am Coll Cardiol，2005，45(3)：351-356.
[10] Kim YH，Park DW，Lee SW，et al.Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents[J].Circulation，2009，120(5)：400-407.
[11] Iakovou I，Schmidt T，Bonizzoni E，et al.Incidence，predictors，and outcome of thrombosis after successful implantation of drug-eluting stents[J].JAMA，2005，293(17)：2126-2130.
[12] Stone GW，Moses JW，Ellis SG，et al.Safety and efficacy of sirolimus and paclitaxel-eluting coronary stents[J].N Engl J Med，2007，356(10)：998-1008.
[13] Mauri L，Hsieh W，Massaro JM，et al.Stent thrombosis in randomized clinical trials of drug-eluting stents[J].N Engl J Med，2007，356(10)：1020-1029.
[14] Kuchulakanti PK，Chu WW，Torguson R，et al.Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus-and paclitaxel-eluting stents[J].Circulation，2006，113(8)：1108-1113.
[15] Kastrati A，Mehilli J，Pache J，et al.Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents[J].N Engl J Med，2007，356(10)：1030-1039.
[16] Tu JV，Bowen J，Chiu M，et al.Effectiveness and safety of drug-eluting stents in Ontario[J].N Engl J Med，2007， 357(14)：1393-1402.
[17] Marroquin OC，Selzer F，Mulukutla SR，et al.A comparison of bare-metal and drug-eluting stents for off-label indications[J].N Engl J Med，2008，358(4)：342-352.
[18] Han Y，Wang S，Jing Q，et al.Comparison of long-term efficacy of the paclitaxel-eluting stent versus the bare-metal stent for treatment of unprotected left main coronary artery disease[J].Am J Cardiol，2009，103(2)：194-198.
[19] Gao R，Xu B，Chen J，et al.Immediate and long-term outcomes of drug-eluting stent implantation for unprotected left main coronary artery disease：comparison with bare-metal stent implantation[J].Am Heart J，2008，155(3)：553-561.
[20] Lagerqvist B，James SK，Stenestrand U，et al.Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden[J].N Engl J Med，2007，356(10)：1009-1019.
(收稿日期：2014-10-31 本文编辑：李亚聪) (翟娜 张宇静 王明毅 关红 徐健)